Xcout Intel
H LUNDBECK A/S H.LUNDBECK
H. Lundbeck A/S is a global pharmaceutical company that focuses exclusively on researching, developing, and commercializing therapies for brain diseases such as neurological and psychiatric disorders. The company serves patients worldwide by providing specialized treatments for conditions like depression, schizophrenia, Alzheimer's disease, and migraine.
Subscribe to see H LUNDBECK A/S H.LUNDBECK’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
H LUNDBECK A/S H.LUNDBECK at a glance
H LUNDBECK A/S H.LUNDBECK is a pharmaceuticals company headquartered in United Kingdom. Xcout tracks 1 named person at H LUNDBECK A/S H.LUNDBECK, including Charl van Zyl (President & CEO).
H LUNDBECK A/S H.LUNDBECK leadership
- Charl van ZylPresident & CEO
H LUNDBECK A/S H.LUNDBECK competitors
A few of H LUNDBECK A/S H.LUNDBECK's closest competitors — see the full list of competitors and alternatives →
Ipsen is a global biopharmaceutical company that researches, develops, and commercializes innovative medicines. It primarily serves patients suffering from conditions in the fields of oncology, rare diseases, and neuroscience.
UCB is a global biopharmaceutical company that develops medicines and digital care solutions for individuals living with severe neurological and autoimmune conditions. The company serves patients and healthcare professionals through scientific research, clinical development, and personalized support services.
Novo Nordisk is a global healthcare company that researches, develops, manufactures, and markets pharmaceutical products. It primarily provides treatments and medical solutions for chronic conditions such as diabetes, obesity, and rare blood and endocrine disorders to serve patients and healthcare professionals.
Grünenthal is a global pharmaceutical company that researches, develops, and commercializes innovative treatments and medicines with a primary focus on pain management and related diseases. Operating as a science-based business, the company serves patients worldwide by delivering therapies for conditions such as chronic pain, rare diseases, and neurobiological indications.
Recordati is a global pharmaceutical company that develops and commercializes medicines for both common and rare diseases. It serves patients across approximately 150 countries through its specialty, primary care, and rare diseases operations.
Orexo AB is a pharmaceutical company that specializes in developing innovative drug delivery technologies, notably its powder-based AmorphOX platform. The company advances proprietary and partnered pharmaceutical products, including treatments, vaccines, and nasal delivery formulations, serving patients and healthcare partners globally.
Get H LUNDBECK A/S H.LUNDBECK's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on H LUNDBECK A/S H.LUNDBECK in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access